141 related articles for article (PubMed ID: 11689147)
1. Clinical evaluation of human telomerase catalytic subunit in bladder washings from patients with bladder cancer.
Fukui T; Nonomura N; Tokizane T; Sato E; Ono Y; Harada Y; Nishimura K; Takahara S; Okuyama A
Mol Urol; 2001; 5(1):19-23. PubMed ID: 11689147
[TBL] [Abstract][Full Text] [Related]
2. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
3. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
Bialkowska-Hobrzanska H; Bowles L; Bukala B; Joseph MG; Fletcher R; Razvi H
Mol Diagn; 2000 Dec; 5(4):267-77. PubMed ID: 11172490
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer.
Weikert S; Krause H; Wolff I; Christoph F; Schrader M; Emrich T; Miller K; Müller M
Int J Cancer; 2005 Nov; 117(2):274-80. PubMed ID: 15900578
[TBL] [Abstract][Full Text] [Related]
5. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection.
Neves M; Ciofu C; Larousserie F; Fleury J; Sibony M; Flahault A; Soubrier F; Gattegno B
J Urol; 2002 Mar; 167(3):1276-81. PubMed ID: 11832713
[TBL] [Abstract][Full Text] [Related]
7. Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker.
Melissourgos N; Kastrinakis NG; Davilas I; Foukas P; Farmakis A; Lykourinas M
Urology; 2003 Aug; 62(2):362-7. PubMed ID: 12893365
[TBL] [Abstract][Full Text] [Related]
8. Detection of telomerase status by semiquantitative and in situ assays, and by real-time reverse transcription-polymerase chain reaction (telomerase reverse transcriptase) assay in bladder carcinomas.
Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
BJU Int; 2003 Apr; 91(6):567-72. PubMed ID: 12656916
[TBL] [Abstract][Full Text] [Related]
9. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.
Ito H; Kyo S; Kanaya T; Takakura M; Koshida K; Namiki M; Inoue M
Clin Cancer Res; 1998 Nov; 4(11):2807-10. PubMed ID: 9829746
[TBL] [Abstract][Full Text] [Related]
10. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas].
Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058
[TBL] [Abstract][Full Text] [Related]
11. Detection of the presence of catalytic subunit mRNA associated with telomerase gene in exfoliated urothelial cells from patients with bladder cancer.
Isurugi K; Suzuki Y; Tanji S; Fujioka T
J Urol; 2002 Oct; 168(4 Pt 1):1574-7. PubMed ID: 12352460
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-alpha-induced apoptosis in bladder cancer cells.
Gao XD; Chen YR
Chin Med J (Engl); 2007 May; 120(9):755-60. PubMed ID: 17531113
[TBL] [Abstract][Full Text] [Related]
13. Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas.
De Kok JB; Schalken JA; Aalders TW; Ruers TJ; Willems HL; Swinkels DW
Int J Cancer; 2000 Jul; 87(2):217-20. PubMed ID: 10861477
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of urinary human telomerase reverse transcriptase mRNA and scatter factor protein as urine markers for diagnosis of bladder cancer.
Eissa S; Motawi T; Badr S; Zaghlool A; Maher A
Clin Lab; 2013; 59(3-4):317-23. PubMed ID: 23724620
[TBL] [Abstract][Full Text] [Related]
15. Real-time quantification of human telomerase reverse transcriptase mRNA in tumors and healthy tissues.
de Kok JB; Ruers TJ; van Muijen GN; van Bokhoven A; Willems HL; Swinkels DW
Clin Chem; 2000 Mar; 46(3):313-8. PubMed ID: 10702516
[TBL] [Abstract][Full Text] [Related]
16. Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay.
Gelmini S; Crisci A; Salvadori B; Pazzagli M; Selli C; Orlando C
Clin Cancer Res; 2000 Jul; 6(7):2771-6. PubMed ID: 10914723
[TBL] [Abstract][Full Text] [Related]
17. Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer.
Eissa S; Swellam M; Ali-Labib R; Mansour A; El-Malt O; Tash FM
J Urol; 2007 Sep; 178(3 Pt 1):1068-72. PubMed ID: 17644139
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of hTERT protein in human tissues.
Yan P; Benhattar J; Seelentag W; Stehle JC; Bosman FT
Histochem Cell Biol; 2004 May; 121(5):391-7. PubMed ID: 15138842
[TBL] [Abstract][Full Text] [Related]
19. Clinical usefulness of telomerase for the detection of colon cancer in ulcerative colitis patients.
Myung SJ; Yang SK; Chang HS; Byeon JS; Kim KJ; Hong SS; Jeong JY; Lee SM; Hong WS; Kim JH; Min YI
J Gastroenterol Hepatol; 2005 Oct; 20(10):1578-83. PubMed ID: 16174077
[TBL] [Abstract][Full Text] [Related]
20. Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts.
Brems-Eskildsen AS; Zieger K; Toldbod H; Holcomb C; Higuchi R; Mansilla F; Munksgaard PP; Borre M; Ørntoft TF; Dyrskjøt L
BMC Cancer; 2010 Nov; 10():646. PubMed ID: 21106093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
